FundsWhat next for private equity trusts?Standout performers from the pandemic face greater uncertaintySave21 February 2022
FundsIBT spies the bottom for beaten-up biotechAfter a torrid year for biotech stocks, shrewd investors can pick up bargains. But risks aboundSave17 February 2022
FundsThe most highly geared investment trustsSome trusts with high gearing could point to appealing marketsSave14 February 2022
FundsWhat to do when you inherit a portfolio of shares and fundsTaking the right administrative steps and tax planning help to maximise the value of an inherited portfolioSave10 February 2022
FundsInvestment trust stability and the art of doing nothingJanuary's sell-off proved relatively quiet, by one measureSave10 February 2022
FundsRathbones' James Thomson on value, rates and the tech sector "Kool Aid"James Thomson tells Dave Baxter how he is dealing with heightened uncertaintySave9 February 2022
Funds3i Infrastructure: pricey or a premium pick?A reader faces up to a common dilemmaSave8 February 2022
FundsNick Train sticks to his guns after tougher yearNick Train tells Leonora Walters why he is sticking with quality companies despite recent underperformanceSave4 February 2022
.jpg?source=specialist-components&quality=low)
.jpg?source=specialist-components&quality=low)
